We support projects at different stages of the innovation pathway to deliver meaningful change to health and care. These are some of the programmes of work and innovations we have supported.
| PROJECT | DESCRIPTION |
|---|---|
Assessing anticipatory care in SNEE |
Health Innovation East has been commissioned by SNEE ICS to conduct an independent baseline review of current readiness within primary care to deliver anticipatory care by April 2023. It is hoped that this can support more integrated care delivery across the ICS. |
Assessing remote monitoring pathways in integrated care systems |
This project aims to evaluate how remote monitoring can track a wide range of conditions at home, and who it can help most. Health Innovation East has partnered with the NIHR Applied Research Collaboration East of England (NIHR ARC EoE) for the programme, with funding from the NHS Insights Prioritisation Programme (NIPP). |
C the Signs – Clinical decision support tool |
C the Signs is an integrated (Systm1 or EMIS) clinical decision support tool to aid cancer diagnosis. It uses AI to support GPs with risk-assessing patients by checking combinations of signs, symptoms, and risk factors, and will then suggesting an appropriate diagnostic pathway. The practice dashboard provides support for patient safety-netting. |
CamAPS FX |
CamAPS FX monitors glucose levels using data provided by a monitor and automatically adjusts the delivery of insulin via a pump, mimicking some of the functions of a healthy pancreas to stabilise glucose levels. It was developed by CamDiab at the University of Cambridge. |
Cardiovascular disease (CVD) prevention programme |
Improving the detection and management of the high-risk conditions atrial fibrillation (AF), high blood pressure and high cholesterol as well as early diagnosis of familial hypercholesterolaemia. |
CareMonitR |
CareMonitR enables GP Practices to automate their recall and monitoring activity for patients with long term conditions and standardise care for multimorbidity management. Using intelligent algorithms, the software automatically identifies patients requiring recall and highlights tests required prior to the patient’s review. CareMonitR is a product from CareDoctR. |
Detecting and monitoring for signs of poor esophageal health |
Cytosponge is a tool to detect Barrett’s Oesophagus – a precursor to oesophageal cancer – which is minimally invasive and can be used in primary care. Using Cytosponge a patient swallows a capsule, about the size of a multi-vitamin pill, which is attached to a cord. When swallowed, the capsule dissolves to release a sponge. The sponge can then be removed by a nurse a few minutes later collecting cells along its passage. These cells are then tested in the laboratory using an accurate method developed by the Fitzgerald Laboratory. Health Innovation East is looking at how to support the use of Cytosponge in primary care across the region. |
C2-Ai |
C2-Ai is an impact enhanced risk analysis tool which aims to help healthcare services manage waiting lists by triaging patients for elective care using key indicators related to efficiency and patient outcomes. This will also be used to develop other AI-based approaches to support the NHS recovery. |
DASHclinic |
DASHclinic is a clinic queue management tool designed to optimise patient flow in outpatients services. It aims to improve healthcare for both patients and medical staff by reducing unnecessary waiting and creating time to care. DASHclinic also includes notetaking, task requesting, and performing smart clinical coding. Health Innovation East is funding an evaluation of the tool. |
Focus ADHD (Attention Deficit Hyperactivity Disorder) |
The Focus ADHD programme aims to transform the diagnosis of ADHD across the region. As part of our Focus ADHD programme we use the QbTest which is an objective assessment tool for the assessment of ADHD. |
Do you have a great idea that could deliver meaningful change in the real world?
Get involved